![]() |
市場調查報告書
商品編碼
2030251
脈動式血氧監測儀系統市場-全球產業規模、佔有率、趨勢、機會和預測:按產品類型、感測器類型、患者類型、最終用戶、地區和競爭格局分類,2021-2031年Pulse Oximeter Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product Type, By Sensor Type, By Patient Type, By End User, By Region & Competition, 2021-2031F |
||||||
全球脈搏血氧飽和度分析儀市場預計將從 2025 年的 40.5 億美元成長到 2031 年的 57.1 億美元,複合年成長率為 5.89%。
該行業的核心是利用通常佩戴在手指上的感測器,以非侵入式方式測量脈搏和血氧飽和度 (SpO2) 的設備。推動這一成長的關鍵因素包括全球呼吸系統疾病(如氣喘和慢性阻塞性肺病(COPD))發病率的上升,以及需要持續健康管理的老年人口不斷增加。此外,遠端患者監護和居家醫療需求的日益成長,以及全球手術數量的增加,也持續推動醫療保健領域對這些設備的需求。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 40.5億美元 |
| 市場規模:2031年 | 57.1億美元 |
| 複合年成長率:2026-2031年 | 5.89% |
| 成長最快的細分市場 | 手持式 |
| 最大的市場 | 北美洲 |
歐洲呼吸學會和世界衛生組織歐洲區域辦事處於2025年6月聯合發布的報告指出,世衛組織歐洲區域人口眾多,其中8,170萬人患有慢性呼吸系統疾病,需要進行血氧飽和度監測。儘管需求強勁,但由於脈搏血氧飽和度分析儀精度會因膚色不同而存在差異,市場成長仍面臨許多障礙。這種可靠性不足可能導致某些人群的醫療延誤和誤診。
全球脈搏血氧飽和度分析儀產業的主要驅動力是呼吸系統疾病發病率的不斷上升,這使得持續監測血氧水平變得至關重要。氣喘和慢性阻塞性肺病(COPD)等呼吸系統疾病需要定期評估,以延緩疾病進展並避免嚴重發作。 2026年1月發表在《自然醫學》雜誌上的一項研究指出,到2023年,全球約有5.7億人患有慢性呼吸系統疾病,這意味著龐大的人群需要脈搏血氧飽和度分析儀等監測設備。這種廣泛的健康負擔使得患者和醫療保健系統都迫切需要可靠、非侵入性的監測方法。
此外,人口老化及其導致的慢性病增加也是推動市場成長的因素之一。老年人罹患糖尿病、心血管疾病和呼吸系統疾病等與老齡化相關的健康問題的風險更高,而這些疾病都需要每日持續的生理監測。世界經濟論壇2025年10月發布的報告預測,全球60歲及以上人口將從2023年的11億增至2030年的14億,這將擴大日益依賴家庭監測和長期照護的人口。這些人口結構變化正在推動對易於使用、攜帶式脈動式血氧監測儀系統進行遠端健康管理的需求。這一趨勢也得到了以下事實的支持:2024年,全球醫院從醫療設備再加工商協會的成員機構採購了超過3600萬件可重複使用的醫療器械,其中包括脈動式血氧監測儀系統感測器。
全球脈搏血氧飽和度分析儀產業發展面臨的一大障礙是,由於膚色差異,這些設備的可靠性已被證實存在問題。這個問題削弱了設備的可靠性,並在醫護人員和病人中引發了質疑,尤其是在多元文化社會中。當血氧儀對某些膚色人群的讀數不準確時,會增加延誤治療和誤診的風險,最終危及患者安全,並削弱人們對這項技術整體能力的信心。
這個問題嚴重限制了市場擴張,因為它可能導致更嚴格的法律規範,並推高生產成本,因為企業需要努力滿足嚴格的測試標準。 2025年1月,美國食品藥物管理局(FDA)發布了指導方針草案,建議製造商將測試對象數量從至少10人增加到150人,並確保至少25%的受試者膚色較深。這項更新的監管政策凸顯了問題的嚴重性,並表明先前的測試方法不足。這迫使製造商投入大量資金來檢驗設備在更多樣化人群中的準確性,從而增加了市場准入難度,並減緩了產品創新。
值得關注的行業趨勢包括脈搏血氧飽和度分析儀的小型化和穿戴式健康技術的蓬勃發展,這些技術將病患監測從醫院擴展到日常生活,成為不可或缺的一部分。這些小巧隱蔽的工具如今已整合到智慧型手錶和戒指等日常用品中,能夠無縫、持續地監測脈搏和血氧飽和度(SpO2)水平。這種便捷的監測方式有助於在醫療機構之外進行預防性健康管理,並快速檢測血氧飽和度下降,從而顯著提高患者的依從性和參與度。這項轉變凸顯了消費者對持續、整合的健康數據日益成長的需求。根據飛利浦2026年2月發布的年度報告,其「互聯關懷」業務部門2025年第四季的同店銷售額成長了7%,顯示消費者對個人健康追蹤技術的需求不斷成長。
更重要的進展是人工智慧驅動的智慧脈搏血氧計的興起。它正將基礎測量設備轉變為先進的預測和診斷系統。透過整合人工智慧,脈動式血氧監測儀系統現在可以評估複雜的生理數據,識別細微的異常,並提供關於患者呼吸健康的預測分析。這些智慧工具透過最大限度地減少誤報和提高數據理解能力,從而實現更有效率的醫療回應。這些改進對於提高診斷準確性和個人化治療至關重要,尤其是在持續遠端監測和複雜的醫療情況下。 GE醫療集團承諾在2025年投資超過17億美元用於創新,包括人工智慧驅動的監測和診斷技術的進步,這正反映了這一趨勢。
The Global pulse oximeter market is anticipated to expand from USD 4.05 billion in 2025 to USD 5.71 billion by 2031, registering a 5.89% compound annual growth rate. This industry centers around instruments utilized to non-invasively track pulse rates and blood oxygen saturation (SpO2), generally via a sensor placed on a finger. Primary catalysts for this growth encompass the rising worldwide incidence of respiratory ailments like asthma and chronic obstructive pulmonary disease, alongside an expanding elderly demographic that often needs continuous health tracking. Additionally, the increasing need for remote patient monitoring and home healthcare, coupled with a higher global volume of surgical operations, continues to drive demand for these devices in medical environments.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 4.05 Billion |
| Market Size 2031 | USD 5.71 Billion |
| CAGR 2026-2031 | 5.89% |
| Fastest Growing Segment | Handheld |
| Largest Market | North America |
A joint report published in June 2025 by the European Respiratory Society and WHO/Europe noted that 81.7 million people in the WHO European Region suffer from chronic respiratory illnesses, highlighting a massive demographic in need of oxygen saturation tracking. Despite this strong demand, market growth faces a notable hurdle due to proven variations in pulse oximeter precision across different skin tones. This unreliability can result in delayed medical care or inaccurate diagnoses for certain demographics.
Market Driver
A major catalyst for the worldwide pulse oximeter industry is the escalating incidence of respiratory illnesses, which makes the continuous tracking of blood oxygen levels essential. Respiratory issues like asthma and chronic obstructive pulmonary disease demand regular evaluation to control the illness's advancement and avoid severe flare-ups. A January 2026 study in Nature Medicine revealed that roughly 570 million individuals globally lived with chronic respiratory conditions in 2023, highlighting a massive patient base that needs monitoring equipment such as pulse oximeters. This extensive health burden creates a strong necessity for both patients and medical systems to utilize reliable, non-invasive tracking methods.
Market growth is additionally fueled by the expanding elderly demographic and their related chronic diseases. Seniors face a higher risk of developing age-linked issues such as diabetes, cardiovascular disorders, and respiratory problems, all of which routinely require ongoing physiological tracking. An October 2025 report from the World Economic Forum estimates that the global population aged 60 and older will climb from 1.1 billion in 2023 to 1.4 billion by 2030, creating an expanding group that often depends on home monitoring and extended care. This shifting demographic fuels the need for easy-to-use, portable pulse oximeters for remote health management, a trend supported by global hospitals purchasing more than 36 million reprocessed single-use tools, including oximeter sensors, from Association of Medical Device Reprocessors members in 2024.
Market Challenge
A major obstacle to the growth of the worldwide pulse oximeter industry is the proven unreliability of these devices across varying skin tones. This issue diminishes the dependability of the equipment and generates skepticism among both medical practitioners and patients, especially within multicultural populations. If oximeters yield incorrect measurements for specific skin colors, it raises the danger of delayed treatments or incorrect diagnoses, ultimately threatening patient safety and eroding trust in the technology's overall capability.
This problem actively restricts market expansion by triggering stricter regulatory oversight and potentially driving up production expenses as companies strive to meet tougher testing standards. In January 2025, the U.S. Food and Drug Administration (FDA) issued draft guidelines advising producers to expand their testing groups from a minimum of 10 people to 150, ensuring that at least 25% of the subjects possess darker skin. This updated regulatory stance underscores the critical nature of the issue, showing that prior testing methods were inadequate and forcing manufacturers to invest heavily to verify device accuracy across a more diverse demographic, thereby complicating market entry and slowing product innovation.
Market Trends
A prominent trend in the industry is the shrinking size of pulse oximeters and the surge in wearable health technology, moving patient monitoring out of hospitals and into daily routines. These small, discreet tools are now built into everyday items such as smartwatches and rings, allowing for seamless and ongoing monitoring of pulse rates and SpO2 levels. Such easy access promotes preventative health tracking and the swift identification of oxygen drops outside of medical facilities, greatly improving patient compliance and involvement. This shift highlights a rising consumer desire for continuous, integrated health data, as supported by Philips' February 2026 annual report showing a 7% rise in Connected Care comparable sales during the final quarter of 2025, demonstrating the growing embrace of personal health tracking technologies.
A further critical development is the rise of AI-enhanced and smart oximetry, transforming basic measuring devices into advanced predictive and diagnostic systems. By incorporating artificial intelligence, pulse oximeters can now evaluate complex physiological data, identify minor irregularities, and deliver predictive analysis regarding a patient's respiratory health. These smart tools also minimize false alerts and enhance data comprehension, resulting in more streamlined medical responses. These upgrades are vital for refining diagnostic precision and customizing treatment, especially during continuous remote tracking or intricate medical situations, a trend mirrored by GE HealthCare's dedication of over USD 1.7 billion to innovation in 2025, encompassing AI-powered monitoring and diagnostic advancements.
Report Scope
In this report, the Global Pulse Oximeter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Pulse Oximeter Market .
Global Pulse Oximeter Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: